Non-Small Cell Lung Cancer

N/V

Veröffentlicht von: @Point of Care

Beschreibung

@Point of Care™ With @sk Cognitive is a clinical decision-making mobile platform. Non-Small Cell Lung Cancer @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care.
With @sk Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Watson, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care.
Non-Small Cell Lung Cancer @Point of Care™ is designed to:
• Support discovery and practice change
• Provide relevant, evidence-based disease-specific medical content
• Improve patient outcomes at the point of care
Features:
• Continually updated Non-Small Cell Lung Cancer content
• Topics in diagnosis, treatment, and care management developed with expert physician authors
• Case studies, videos, and interviews
• Access to actionable patient-recorded data
• Detailed reference list with access to original sources
• Continuing medical education credit (CME/CE)
• Surveys and peer polling
• Patient education resources to share with patients
• BreakingMED™ news feed
Ausblenden Mehr anzeigen...

Screenshots

Non-Small Cell Lung Cancer Häufige Fragen

  • Ist Non-Small Cell Lung Cancer kostenlos?

    Ja, Non-Small Cell Lung Cancer ist komplett kostenlos und enthält keine In-App-Käufe oder Abonnements.

  • Ist Non-Small Cell Lung Cancer seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet Non-Small Cell Lung Cancer?

    Non-Small Cell Lung Cancer ist kostenlos.

  • Wie hoch ist der Umsatz von Non-Small Cell Lung Cancer?

    Um geschätzte Einnahmen der Non-Small Cell Lung Cancer-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung

4 von 5

1 Bewertungen in Dänemark

5 star
0
4 star
1
3 star
0
2 star
0
1 star
0
Bewertungsverlauf

Non-Small Cell Lung Cancer Bewertungen

Very good textbook on NSCLC

mcclousky on

Dänemark

An easy to read textbook on the newest guidelines for diagnosing, staging and treating NSCLC. It includes good references for further reading. Selected words are hyperlinks to Wikipedia, which is a good detail. As an intern with a special interest in the field I find the educational level very suitable, not too high to require too much brain power, and yet very learnful. A well thought out detail is the ability to earn CME/CE credits upon reading the text. As a suggestion I would make links to the references in the text so it is easy to jump back and forth when reading.

X

tsjbrmcrblgngtb on

Vereinigte Staaten

Very helpful. Thanks.

Store-Rankings

Ranking-Verlauf
App-Ranking-Verlauf noch nicht verfügbar
Kategorien-Rankings
App ist noch nicht gerankt

Schlüsselwörter

Non-Small Cell Lung Cancer Konkurrenten

Name
Manual of Clinical Oncology
with Expert Recommentations
ChemoSafe
Assessing chemotherapy safety
Neuro-Oncology Trials App
Neuro-oncology: WTD
What's the data?
Physicians Cancer Chemotherapy
Clinical Therapy Drug Guide
Lung Cancer Screen
Screening Tool and Calculator
TNM Cancer Staging System
AJCC Licensed Content V9
Esophageal Cancer Stage
iBronch
Video Bronchoscopy
ALTAI Oncology

Non-Small Cell Lung Cancer Installationen

Letzte 30 Tage

Non-Small Cell Lung Cancer Umsatz

Letzte 30 Tage

Non-Small Cell Lung Cancer Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von Non-Small Cell Lung Cancer mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.